- Home
- RNA vs UMBF Comparison
RNA vs UMBF Comparison
Compare RNA & UMBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- UMBF
- Stock Information
- Founded
- RNA 2012
- UMBF 1913
- Country
- RNA United States
- UMBF United States
- Employees
- RNA N/A
- UMBF N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- UMBF Major Banks
- Sector
- RNA Health Care
- UMBF Finance
- Exchange
- RNA Nasdaq
- UMBF Nasdaq
- Market Cap
- RNA 4.4B
- UMBF 5.2B
- IPO Year
- RNA 2020
- UMBF N/A
- Fundamental
- Price
- RNA $32.74
- UMBF $120.15
- Analyst Decision
- RNA Strong Buy
- UMBF Buy
- Analyst Count
- RNA 10
- UMBF 7
- Target Price
- RNA $63.60
- UMBF $123.14
- AVG Volume (30 Days)
- RNA 1.1M
- UMBF 318.7K
- Earning Date
- RNA 11-07-2024
- UMBF 01-28-2025
- Dividend Yield
- RNA N/A
- UMBF 1.33%
- EPS Growth
- RNA N/A
- UMBF 2.85
- EPS
- RNA N/A
- UMBF 8.01
- Revenue
- RNA $10,117,000.00
- UMBF $1,523,550,000.00
- Revenue This Year
- RNA N/A
- UMBF N/A
- Revenue Next Year
- RNA N/A
- UMBF $46.14
- P/E Ratio
- RNA N/A
- UMBF $15.01
- Revenue Growth
- RNA N/A
- UMBF 7.93
- 52 Week Low
- RNA $8.37
- UMBF $76.00
- 52 Week High
- RNA $56.00
- UMBF $129.94
- Technical
- Relative Strength Index (RSI)
- RNA 30.43
- UMBF 47.63
- Support Level
- RNA $32.04
- UMBF $119.07
- Resistance Level
- RNA $34.35
- UMBF $123.55
- Average True Range (ATR)
- RNA 2.07
- UMBF 2.83
- MACD
- RNA -0.55
- UMBF -1.05
- Stochastic Oscillator
- RNA 6.24
- UMBF 18.29
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
About UMBF UMB Financial Corporation
UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking, asset management, and health spending solutions. Its customer base includes commercial, institutional, and personal customers across the United States. The company's banking subsidiaries own and operate banking and wealth-management centers mostly throughout the Midwest and Southwest regions of the U.S. Subsidiaries of the holding company and its lead bank, UMB Bank, include mutual fund and alternative investment services groups, single-purpose companies that deal with brokerage services and insurance, and a registered investment advisory. The bank's revenue is split nearly evenly between interest income and noninterest income.